Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2018, Article ID 8524063, 11 pages
https://doi.org/10.1155/2018/8524063
Research Article

Doctors’ Knowledge of Hypertension Guidelines Recommendations Reflected in Their Practice

1Faculty of Pharmacy and Health Sciences, University of Balochistan, Balochistan, Pakistan
2Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia
3Department of Pharmacy, Quaid-e-Azam University, Islamabad, Pakistan
4Department of Pharmacy, The Islamia University, Bahawalpur, Pakistan

Correspondence should be addressed to Nafees Ahmad; moc.liamg@bouseefan

Received 3 November 2017; Revised 8 February 2018; Accepted 12 February 2018; Published 12 March 2018

Academic Editor: Franco Veglio

Copyright © 2018 Nafees Ahmad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Quek, “The Malaysian Health Care System: A Review,” 1-11, 2014, https://www.researchgate.net/publication/237409933_The_Malaysian_Health_Care_System_A_Review.
  2. Institute for Public Health, “National health and morbidity survey 2015,” in Non-Communicable Diseases, Risk Factors and Other Health Problems, vol. 2, p. 291, Ministry of Health, Kuala Lumpur, Malaysia, 2015. View at Google Scholar
  3. S. Teoh, A. Razlina, D. Norwati, and M. S. Siti, “Patients' blood pressure control and doctors' adherence to hypertension clinical practice guideline in managing patients at health clinics in Kuala Muda district, Kedah,” Medical Journal of Malaysia, vol. 72, no. 1, pp. 18–25, 2017. View at Google Scholar
  4. N. Ahmad, Y. Hassan, B. Tangiisuran et al., “Guidelines adherence and hypertension control at a tertiary hospital in Malaysia,” Journal of Evaluation in Clinical Practice, vol. 19, no. 5, pp. 798–804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Asmar, A. Achouba, P. Brunel, R. El Feghali, T. Denolle, and B. Vaisse, “A specific training on hypertension guidelines improves blood pressure control by more than 10% in hypertensive patients: the VALNORM study,” Journal of the American Society of Hypertension, vol. 1, no. 4, pp. 278–285, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. G. Rowan, J. R. Turner, A. Shah, and J. A. Spaeder, “Antihypertensive treatment and blood pressure control relative to hypertension treatment guidelines,” Pharmacoepidemiology and Drug Safety, vol. 23, no. 12, pp. 1294–1302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Li, A.-P. Cai, Y.-J. Mo et al., “Effects of guideline-based hypertension management in rural areas of Guangdong Province,” Chinese Medical Journal, vol. 128, no. 6, pp. 799–803, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Jackson, J. Sobolski, R. Krienke, K. S. Wong, F. Frech-Tamas, and B. Nightengale, “Blood pressure control and pharmacotherapy patterns in the United States before and after the release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines,” Journal of the American Board of Family Medicine, vol. 21, no. 6, pp. 512–521, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Levy, L. M. Gerber, X. Wu, and S. J. Mann, “Nonadherence to recommended guidelines for blood pressure measurement,” The Journal of Clinical Hypertension, vol. 18, no. 11, pp. 1157–1161, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Basopo and P. N. Mujasi, “To what extent do prescribing practices for hypertension in the private sector in Zimbabwe follow the national treatment guidelines? An analysis of insurance medical claims,” Journal of Pharmaceutical Policy and Practice, vol. 10, no. 1, p. 37, 2017. View at Google Scholar
  11. A. S. Ramli, M. Miskan, K. K. Ng et al., “Prescribing of antihypertensive agents in public primary care clinics - is it in accordance with current evidence,” Malaysian Family Physician, vol. 5, no. 1, pp. 36–40, 2010. View at Google Scholar · View at Scopus
  12. N. Ahmad, Y. Hassan, B. Tangiisuran, O. L. Meng, N. A. Aziz, and A. H. Khan, “Guidelines adherence and hypertension control in an outpatient cardiology clinic in Malaysia,” Tropical Journal of Pharmaceutical Research, vol. 11, no. 4, pp. 665–672, 2012. View at Google Scholar · View at Scopus
  13. G.-C. Chan, “Type 2 diabetes mellitus with hypertension at primary healthcare level in Malaysia: are they managed according to guidelines?” Singapore Medical Journal, vol. 46, no. 3, pp. 127–131, 2005. View at Google Scholar · View at Scopus
  14. S. Raju, S. Solomon, N. Karthik, A. C. Joseph, and Venkatanarayanan, “Assessment of prescribing pattern for hypertension and comparison with jnc-8 guidelines-proposed intervention by clinical pharmacist,” Journal of Young Pharmacists, vol. 8, no. 2, pp. 133–135, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. A. R. Adedeji, J. Tumbo, and I. Govender, “Adherence of doctors to a clinical guideline for hypertension in Bojanala district, North-West Province, South Africa,” African Journal of Primary Health Care and Family Medicine, vol. 7, no. 1, pp. 1–6, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Theodorou, P. Stafylas, G. Kourlaba, D. Kaitelidou, N. Maniadakis, and V. Papademetriou, “Physicians' perceptions and adherence to guidelines for the management of hypertension: a national, multicentre, prospective study,” International Journal of Hypertension, vol. 2012, Article ID 503821, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Midlöv, R. Ekesbo, L. Johansson et al., “Barriers to adherence to hypertension guidelines among GPs in southern Sweden: a survey,” Scandinavian Journal of Primary Health Care, vol. 26, no. 3, pp. 154–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. K. A. Al-Ali, F. A. Al-Ghanim, A. M. Al-Furaih, N. Al-Otaibi, G. Makboul, and M. K. El-Shazly, “Awareness of hypertension guidelines among family physicians in primary health care,” Alexandria Journal of Medicine, vol. 49, no. 1, pp. 81–87, 2013. View at Publisher · View at Google Scholar
  19. S. I. Al-Azzam, R. B. Najjar, and Y. S. Khader, “Awareness of physicians in Jordan about the treatment of high blood pressure according to the seventh report of the Joint National Committee (JNC VII),” European Journal of Cardiovascular Nursing, vol. 6, no. 3, pp. 223–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. H. Jafar, S. Jessani, F. H. Jafary et al., “General practitioners' approach to hypertension in urban Pakistan: disturbing trends in practice,” Circulation, vol. 111, no. 10, pp. 1278–1283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Cuspidi, I. Michev, S. Mean et al., “Awareness of hypertension guidelines in primary care: results of a regionwide survey in Italy,” Journal of Human Hypertension, vol. 17, no. 8, pp. 541–547, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. M. D. Cabana, C. S. Rand, N. R. Powe et al., “Why don't physicians follow clinical practice guidelines? A framework for improvement,” Journal of the American Medical Association, vol. 282, no. 15, pp. 1458–1465, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. A. N. Long and S. Dagogo-Jack, “Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection,” The Journal of Clinical Hypertension, vol. 13, no. 4, pp. 244–251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Siegel and J. Lopez, “Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing?” Journal of the American Medical Association, vol. 278, no. 21, pp. 1745–1748, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. P. E. Drawz, C. Bocirnea, K. B. Greer, J. Kim, F. Rader, and P. Murray, “Hypertension guideline adherence among nursing home patients,” Journal of General Internal Medicine, vol. 24, no. 4, pp. 499–503, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Russell, P. Dunbar, S. Salisbury, I. Sketris, and G. Kephart, “Hypertension control: Results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines,” Cardiovascular Diabetology, vol. 4, article no. 11, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. D. J. Hyman and V. N. Pavlik, “Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine,” JAMA Internal Medicine, vol. 160, no. 15, pp. 2281–2286, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. A. S. Adams, S. B. Soumerai, J. Lomas, and D. Ross-Degnan, “Evidence of self-report bias in assessing adherence to guidelines,” International Journal for Quality in Health Care, vol. 11, no. 3, pp. 187–192, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Considine, M. Botti, and S. Thomas, “Design, format, validity and reliability of multiple choice questions for use in nursing research and education,” Journal of the Royal College of Nursing Australia, vol. 12, no. 1, pp. 19–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Hagemeister, C. A. Schneider, S. Barabas et al., “Hypertension guidelines and their limitations - The impact of physicians' compliance as evaluated by guideline awareness,” Journal of Hypertension, vol. 19, no. 11, pp. 2079–2086, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. W. J. Elliott and P. M. Meyer, “Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis,” The Lancet, vol. 369, no. 9557, pp. 201–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. L. H. Lindholm, B. Carlberg, and O. Samuelsson, “Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis,” The Lancet, vol. 366, no. 9496, pp. 1545–1553, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Rashidian, M. P. Eccles, and I. Russell, “Falling on stony ground? A qualitative study of implementation of clinical guidelines' prescribing recommendations in primary care,” Health Policy, vol. 85, no. 2, pp. 148–161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Olesen and T. Lauritzen, “Do general practitioners want guidelines?: attitudes toward a county- based and a national college-based approach,” Scandinavian Journal of Primary Health Care, vol. 15, no. 3, pp. 141–145, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. S. J. Houlihan, S. H. Simpson, A. J. Cave et al., “Hypertension treatment and control rates: chart review in an academic family medicine clinic,” Canadian Family Physician, vol. 55, no. 7, pp. 735–741, 2009. View at Google Scholar · View at Scopus
  36. S. A. Oliveria, P. Lapuerta, B. D. McCarthy, G. J. L'Italien, D. R. Berlowitz, and S. M. Asch, “Physician-related barriers to the effective management of uncontrolled hypertension,” JAMA Internal Medicine, vol. 162, no. 4, pp. 413–420, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Holland, D. Segraves, V. O. Nnadi, D. A. Belletti, J. Wogen, and S. Arcona, “Identifying barriers to hypertension care: implications for quality improvement initiatives,” Population Health Management, vol. 11, no. 2, pp. 71–77, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Wae, C. Man, L. Tong, C. Wan, C. Yuk, and Y. Street, “Are we evidence-based in prescribing for hypertension?” Asia Pacific Journal of Family Medicine, vol. 5, no. 3, 2006. View at Google Scholar
  39. J. D. Piette and E. A. Kerr, “The impact of comorbid chronic conditions on diabetes care,” Diabetes Care, vol. 29, no. 3, pp. 725–731, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. A. El-Solh, A. Alhajhusain, R. G. Saliba, and P. Drinka, “Physicians' attitudes toward guidelines for the treatment of hospitalized nursing home-acquired pneumonia,” Journal of the American Medical Directors Association, vol. 12, no. 4, pp. 270–276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Ikeda, T. Hasegawa, T. Hasegawa, I. Saito, and T. Saruta, “Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2000) and compliance to its recommendations: surveys in 2000 and 2004,” Journal of Human Hypertension, vol. 20, no. 4, pp. 263–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. O. Berwanger, H. P. Guimarães, L. N. Laranjeira et al., “Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial,” Journal of the American Medical Association, vol. 307, no. 19, pp. 2041–2049, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. J. E. Squires, K. Sullivan, M. P. Eccles, J. Worswick, and J. M. Grimshaw, “Are multifaceted interventions more effective than single-component interventions in changing health-care professionals' behaviours? An overview of systematic reviews,” Implementation Science, vol. 9, no. 1, article no. 152, 2014. View at Publisher · View at Google Scholar · View at Scopus